Essentially, semaglutide helps you feel full longer and reduces your appetite by mimicking a hormone in your body that controls hunger
It can begin within days of the first injection, though it is often subtle at starting doses
Polyethylene glycol is particularly well-tolerated and does not typically cause electrolyte disturbances when used as directed
However, this benefit has not been proven in randomized controlled trials specific to inflammatory bowel disease, and individual responses vary widely based on genetic factors, disease severity, and concurrent medications
These recommendations are also included in guidelines from the European Society for Cardiology [11] and the American Heart Association/American Stroke Association [12]
It can increase the risk of cancer, diabetes, hepatitis, and Parkinsons disease